FHC
GILD icon

First Houston Capital’s Gilead Sciences GILD Stock Holding History

First Houston Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-18,950
Closed -$1.36M – 66
2016
Q4 		$1.36M Sell
18,950
-9,000
-32% -$669K 1.31% 32
2016
Q3 		$2.21M Sell
27,950
-2,250
-7% -$183K 2.23% 21
2016
Q2 		$2.52M Sell
30,200
-285
-0.9% -$25.3K 2.33% 12
2016
Q1 		$2.8M Buy
30,485
+1,900
+7% +$171K 2.67% 11
2015
Q4 		$2.89M Sell
28,585
-150
-0.5% -$15.6K 2.63% 9
2015
Q3 		$2.82M Sell
28,735
-500
-2% -$55.5K 2.66% 9
2015
Q2 		$2.87M Hold
29,235
– – 2.56% 13
2015
Q1 		$2.87M Hold
29,235
– – 2.51% 13
2014
Q4 		$2.76M Sell
29,235
-1,415
-5% -$146K 2.44% 13
2014
Q3 		$3.26M Sell
30,650
-1,150
-4% -$113K 3.05% 2
2014
Q2 		$2.64M Sell
31,800
-1,100
-3% -$85.6K 2.52% 15
2014
Q1 		$2.33M Sell
32,900
-750
-2% -$58.8K 2.28% 21
2013
Q4 		$2.53M Sell
33,650
-400
-1% -$27.9K 2.48% 13
2013
Q3 		$2.14M Buy
+34,050
New +$2.04M 2.3% 18

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

First Houston Capital's GILD Position: Q1 2017 in Review

First Houston Capital sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 18,950 shares — an estimated $1.36M sold.

First Houston Capital first reported a position in GILD in Q3 2013 and held it in 14 quarters. The position peaked at $3.26M in Q3 2014. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • First Houston Capital reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
  • First Houston Capital sold 18,950 Gilead Sciences shares in Q1 2017, an estimated $1.36M.
  • First Houston Capital first reported a position in Gilead Sciences in Q3 2013 and held it in 14 quarters.
  • First Houston Capital's Gilead Sciences position peaked at $3.26M in Q3 2014.
  • 1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on First Houston Capital's 13F filing for Q1 2017, filed 1 May 2017.